Rare diseases
Investigational molecules
Locations
1155 Camino Del Mar, Suit 481, 92014-2605, United States
Celecor Therapeutics Inc. is focused on acute cardiovascular intervention in the setting of ST-segment elevation myocardial infarction (STEMI), with research centered on patients presenting with ongoing ischemic chest pain and diagnostic electrocardiographic changes.
The sponsor’s clinical activity is directed toward urgent treatment pathways for suspected heart attack care across multiple active sites.
Celecor Therapeutics Inc. runs clinical trials in conditions such as Acute myocardial infarction, Myocardial ischaemia, Platelet aggregation test, Platelet aggregation inhibition, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
